Abbott Laboratories, Inc.

Abbott Laboratories, Inc. — FDA 510(k) Submissions

Abbott Laboratories, Inc. has submitted 6 FDA 510(k) premarket notifications since 2002, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Valproic Acid, Pump, Infusion, Cyclosporine, Catheter, Angioplasty, Peripheral, Transluminal, System, Test, Blood Glucose, Over The Counter . Use the specialty filter in the sidebar to narrow results.